Is Asarfi Hospital the Best Stock in Its Sector? A Look at the Numbers
- October 21, 2026
- Posted by: Ankit Jaiswal
- Category: Market
Asarfi Hospital CMP Rs 188 (21 Oct 2026). Market cap Rs 371 Cr. ROE 17.47%. P/E 20.83x versus Industry P/E 59.59x.
Quick Answer
Asarfi Hospital is one of the names investors compare when screening the Hospital Services sector. Whether it is the best stock in its sector depends on whether an investor prioritises return ratios, valuation or balance sheet strength. This article sets it against two named peers and the sector benchmark so you can judge for yourself.
Is Asarfi Hospital the best stock in its sector? The stock trades on the BSE at Rs 188 as of 21 October 2026, within its 52-week range of Rs 135.00 to Rs 256.95. The sections below cover the business, the key ratios, a peer comparison and a closer look at valuation.
Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers
Click Here – Get Free Investment Predictions
About Asarfi Hospital
Asarfi Hospital Ltd provides primary health services and treatment along with specialised super speciality care, and company information says it was incorporated in 2005. It is listed on the BSE SME platform. The company says its super speciality hospital in Baramuri, Dhanbad is the first and only such facility in the Dhanbad region, and that its cancer institute in Ranguni, Dhanbad is the only dedicated cancer hospital within 200 km. The cancer institute has 65 beds with plans to expand to 150, and the company also has a research institute site in Ranchi. At a market capitalisation of Rs 371 Cr, it is tracked as part of the Hospital Services sector on Univest.
Is Asarfi Hospital the Best Stock in Its Sector?
Asarfi Hospital makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, backed by its return on equity. Asarfi Hospital’s 20.83x P/E is below the 59.59x Industry P/E, Narayana Hrudayalaya at 42.28x and Rainbow Children’s Medicare at 43.38x, while its 17.47% ROE is lower than Narayana Hrudayalaya at 17.76%, though higher than Rainbow Children’s Medicare at 16.89%, and its debt to equity ratio of 0.54 is below Narayana Hrudayalaya at 1.29, and in line with Rainbow Children’s Medicare at 0.54.
| Metric | Asarfi Hospital |
|---|---|
| CMP (BSE) | Rs 188.50 |
| 52-Week High / Low | Rs 256.95 / Rs 135.00 |
| Market Cap | Rs 371 Cr |
| P/E (TTM) vs Industry P/E | 20.83x vs 59.59x |
| P/B | 3.64 |
| ROE | 17.47% |
| EPS (TTM) | Rs 9.05 |
| Dividend Yield | 0.00% |
| Debt to Equity | 0.54 |
Compare Asarfi Hospital Against Other Hospital Services Sector Stocks
How Asarfi Hospital Compares Against Its Hospital Services Sector Peers
The table below sets Asarfi Hospital against 2 other Hospital Services sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.
| Company | Market Cap (Rs Cr) | P/E | ROE | Debt to Equity |
|---|---|---|---|---|
| Asarfi Hospital | 371 | 20.83 | 17.47% | 0.54 |
| Narayana Hrudayalaya | 34,527 | 42.28 | 17.76% | 1.29 |
| Rainbow Children’s Medicare | 12,593 | 43.38 | 16.89% | 0.54 |
| Peer average (2 companies) | – | 42.83 | 17.33% | 0.92 |
Measured against the peer averages, Asarfi Hospital’s P/E is 51 percent below the 42.83x average, and its ROE is almost level with the 17.33% average. An average of just two companies is a rough guide, so treat the gap as a pointer for further research and not as a verdict.
What Makes Asarfi Hospital Worth Watching in Hospital Services
- Scale: At Rs 371 Cr, its market capitalisation is smaller than Narayana Hrudayalaya (Rs 34,527 Cr) and Rainbow Children’s Medicare (Rs 12,593 Cr), which is a useful reminder that the peers differ in size as well as in valuation.
- Sector drivers: Bed additions at the cancer institute and patient inflow from the Dhanbad region decide revenue, and a stronger case mix may lift margins.
- Key risk: A regional hospital operator relies on one catchment area and on doctors and equipment it must keep adding, and expansion plans need capital. Being on an SME platform also means thinner trading than larger hospital chains.
Asarfi Hospital Valuation: Is It Justified?
At a P/B ratio of 3.64, the market pays about Rs 3.64 for every rupee of book value, and the EPS (TTM) of Rs 9.05 is the earnings base behind the P/E. The stock trades about 27 percent below its 52-week high and about 40 percent above its 52-week low. The company does not currently show a dividend yield, so returns for shareholders depend mainly on the share price. As with any single stock, investors should weigh these figures against their own valuation discipline and risk appetite rather than the sector label alone.
Also read – Is Oracle Financial Services Software the Best Stock in Its Sector? A Look at the Numbers
Download the Univest iOS App or Univest Android App to track Asarfi Hospital and other Hospital Services sector stocks.
How to Track Asarfi Hospital Before You Invest
Before deciding whether Asarfi Hospital deserves its label as the best stock in its sector for your own portfolio, compare it directly against Hospital Services sector peers using the steps below.
- Open the Univest Screener and search for Asarfi Hospital to view live price, valuation ratios, and peer comparisons within the Hospital Services sector.
- Compare its P/E, P/B, and ROE against other Hospital Services sector stocks before deciding if the current valuation fits your strategy.
- Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
- Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.
Conclusion
Asarfi Hospital gives investors a clear set of numbers to work with, from returns and valuation to leverage and peer standing. Whether it earns the label of best stock in Hospital Services depends on how much weight you give each of them and on how the business executes from here. Because the stock trades below its sector benchmark, the open question is whether earnings growth will close that gap or whether the discount is deserved. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Is Asarfi Hospital the best stock in its sector?
Ans. There is no single definitive answer, because the best stock in a sector depends on whether an investor is prioritising returns, valuation or balance sheet strength. Asarfi Hospital has a 17.47% ROE and trades at 20.83x P/E against a 59.59x Industry P/E. Against the 2 peers compared in this article, its ROE is above the 17.33% peer average and its P/E is below the 42.83x peer average. Its debt to equity ratio of 0.54 is below the 0.92 peer average, which matters because borrowing can inflate returns and add risk when business conditions weaken. These figures are best read together rather than in isolation, and they work as a starting point for your own research and not as a verdict.
What is the current share price of Asarfi Hospital?
Ans. Asarfi Hospital was trading at Rs 188.50 on the BSE as of 21 October 2026, and its 52-week range runs from Rs 135.00 to Rs 256.95. That leaves the share price 27 percent short of the 52-week high and 40 percent clear of the 52-week low. Its market capitalisation is Rs 371 Cr and its EPS (TTM) is Rs 9.05, which is the earnings figure behind the 20.83x P/E. Share prices change through the trading day, so check the live quote on Univest before acting on any number here.
What sector does Asarfi Hospital belong to?
Ans. Asarfi Hospital is classified under the Hospital Services sector on Univest, and that group of listed companies is the reference point for the 59.59x Industry P/E used in this article. The 2 named peers compared here are Narayana Hrudayalaya and Rainbow Children’s Medicare, chosen as comparable listed names so that the P/E, ROE and debt figures come from the same live data source. Investors who want a wider view can compare more Hospital Services sector stocks on the Univest Screener, since no two companies in a sector have exactly the same business mix.
How does Asarfi Hospital compare to its sector peers on P/E?
Ans. Asarfi Hospital’s P/E of 20.83x is below the 42.83x average of the 2 named peers, with Narayana Hrudayalaya at 42.28x and Rainbow Children’s Medicare at 43.38x. It also sits below the 59.59x Industry P/E, which is the benchmark for the wider Hospital Services sector. A P/E that is below a peer average can reflect a valuation discount or premium, but it can also reflect different growth or return expectations, so it should be read alongside ROE and debt. Its P/B ratio of 3.64 gives one more view of how the market values its book value.
What is Asarfi Hospital’s return on equity?
Ans. Asarfi Hospital reported a return on equity of 17.47%, which is above the 17.33% average of its named peers, with Narayana Hrudayalaya at 17.76% and Rainbow Children’s Medicare at 16.89%. ROE shows how much profit a company generates on every rupee of shareholders’ equity, so a higher figure generally points to more efficient use of capital. ROE is easier to trust when leverage is modest, and here the debt to equity ratio is 0.54 against a peer average of 0.92. It is worth checking whether the ROE has been stable over several years rather than relying on a single reading.
Should I invest in Asarfi Hospital based on its sector position?
Ans. Sector position is only one input into an investment decision. Asarfi Hospital has a 17.47% ROE and a 20.83x P/E, which make it worth researching further, and its dividend yield is 0.00%. You should also weigh its business outlook, earnings consistency, debt levels, your investment horizon and your own risk appetite before buying. Spreading money across several stocks and sectors reduces concentration risk, and this article is educational content, not investment advice. For personalised guidance, consult a SEBI-registered advisor.
